Search this site
Board of Directors
News & Events
Patents - Publications
Technology - Strong Preclinical Data
Mice were injected on Day 1 with lung tumor cells.
On Day 3, a subset of the mice was injected with tumor-specific T cells.
On days 4, 5, and 6, aAPCs were injected into a subset of the mice that received tumor-specific T cells.
The results are depicted in the graph at right
2016 NexImmune. All Rights Reserved.